Intech Biopharm Ltd(TW:6461)
NT$26.550.40 (-0.56%)
TW:6461
Intech Biopharm Ltd financials statements
NT$26.55
At close:0.40 (-0.56%)
Intech Biopharm Ltd (6461) Financial Statements
Intech Biopharm Ltd Financial Overview
Intech Biopharm Ltd's market cap is currently NT$2.94B. The company's EPS TTM is NT$-4.51; its P/E ratio is -5.89; Intech Biopharm Ltd has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 107.53M | NT$ 39.78M | NT$ 25.85M | NT$ 23.65M | NT$ 38.90M |
| Gross Profit | NT$ -120.12M | NT$ -157.63M | NT$ -164.00M | NT$ -147.26M | NT$ -119.37M |
| Operating Income | NT$ -364.50M | NT$ -356.13M | NT$ -320.47M | NT$ -304.84M | NT$ -282.22M |
| EBITDA | NT$ -273.24M | NT$ -246.70M | NT$ -219.59M | NT$ -219.48M | NT$ -197.40M |
| Net Income | NT$ -389.03M | NT$ -368.21M | NT$ -337.99M | NT$ -327.88M | NT$ -301.76M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 214.30M | NT$ 258.68M | NT$ 598.13M | NT$ 374.94M | NT$ 335.48M |
| Total Assets | NT$ 2.35B | NT$ 2.40B | NT$ 2.71B | NT$ 2.55B | NT$ 2.60B |
| Total Debt | NT$ 1.19B | NT$ 1.44B | NT$ 1.44B | NT$ 1.41B | NT$ 1.15B |
| Net Debt | NT$ 1.17B | NT$ 1.24B | NT$ 1.36B | NT$ 1.34B | NT$ 931.94M |
| Total Liabilities | NT$ 1.25B | NT$ 1.58B | NT$ 1.54B | NT$ 1.52B | NT$ 1.26B |
| Stockholders' Equity | NT$ 1.10B | NT$ 814.28M | NT$ 1.17B | NT$ 1.03B | NT$ 1.34B |
| Cash Flow | |||||
| Free Cash Flow | NT$ -425.14M | NT$ -312.84M | NT$ -234.34M | NT$ -201.39M | NT$ -221.91M |
| Operating Cash Flow | NT$ -361.13M | NT$ -269.22M | NT$ -232.09M | NT$ -190.39M | NT$ -200.61M |
| Investing Cash Flow | NT$ -197.48M | NT$ 422.37M | NT$ -240.21M | NT$ -205.94M | NT$ -35.52M |
| Financing Cash Flow | NT$ 377.28M | NT$ -32.43M | NT$ 485.20M | NT$ 238.71M | NT$ 251.92M |
Currency in TWD

